Topics and Expertise: QBI Coronavirus Research Group

QBI Coronavirus Research Group identifies drugs that block SARS-CoV-2 in the laboratory

Thu May 28, 2020
Group in conference room
Susan Merrell

Nevan Krogan, PhD (standing), leads a meeting of the QBI Coronavirus Research Group with fellow UCSF faculty members (seated from left) Danica Galonić Fujimori, PhD; Natalia Jura, PhD; James Fraser, PhD; and David Agard, PhD.

The QBI Coronavirus Research Group found six drugs that effectively beat back SARS-COV-2 in the laboratory.

UCSF team has discovered drugs that block coronavirus, paving way for ‘a better drug sooner’

Thu May 7, 2020

QBI Coronavirus Research Group races toward a cure

Tue Mar 31, 2020
SARS-COV2 virus particles on human cells
NIH

SARS-COV2 virus particles (orange), which cause COVID-19, on human cells (blue).

The UCSF Quantitative Biosciences Institute has made headway identifying dozens of potential therapies for the COVID-19 outbreak.

Hunting for a cure for COVID-19: an insider’s story

Sat Mar 21, 2020
Krogan and Fabius

QBI’s director, Nevan Krogan, PhD, left, and Jacqueline Fabius, QBI's chief operating officer

The chief operating officer of the Quantitative Biosciences Institute (QBI) shares a view of the team's work on COVID-19.

Pages